P-glikoprotein — разлика између измена

'''P-glikoprotein 1''' (glikoprotein permeabilnosti, -{''P-gp'', ''Pgp''}-, ''protein otpornosti na višestruke lekove 1'', MDR1, ''ATP-vezujuća kaseta potfamilija B član 1'', ABCB1, ''klaster of diferencijacije 243'', -{CD243}-) je [[glikoprotein]] koji je kod ljudi kodiran -{''ABCB1''}- [[gen]]om.<ref name="pmid3027054">{{cite journal | author = Ueda K, Clark DP, Chen CJ, Roninson IB, Michael M. Gottesman, Pastan I | title = The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation | journal = J. Biol. Chem. | volume = 262 | issue = 2 | pages = 505–8 | year = 1987 | month = January | pmid = 3027054 | doi = | url =http://www.jbc.org/cgi/content/abstract/262/2/505 }}</ref> -{P-gp}- dobro poznati [[ABC-transporter]] (koji transportuje široki opseg supstrata kroz ekstra- i intracelularne membrane). On je član [[Otpornost na višestruke lekove|MDR]]/[[Transporter asociran sa obradom antigena|TAP]] familije.<ref name="ABC_Transporter_Superfamily">{{cite web | url = http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mono_001.chapter.137 | title = The Human ATP-Binding Cassette (ABC) Transporter Superfamily | accessdate = 2. 3. 2008. | author last= Dean, |first=Michael | authorlink = | coauthors = | date = 1. 11. 2002. | format = | work = | publisher = National Library of Medicine (US), NCBI | pages = | language = | archiveurl = | archivedate = | quote = }}</ref>

* {{cite journal | author=Ling V |title=Multidrug resistance: molecular mechanisms and clinical relevance |journal=Cancer Chemother. Pharmacol. |volume=40 Suppl |issue= 7|pages= S3–8 |year= 1997 |pmid= 9272126 |doi=10.1007/s002800051053 }}

* {{cite journal | author=Kerb R, Hoffmeyer S, Brinkmann U |title=ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2 |journal=Pharmacogenomics |volume=2 |issue= 1 |pages= 51–64 |year= 2001 |pmid= 11258197 |doi= 10.1517/14622416.2.1.51 }}

* {{cite journal | author=Akiyama S |title=[Mechanisms of drug resistance and reversal of the resistance] |journal=Hum. Cell |volume=14 |issue= 4 |pages= 257–60 |year= 2002 |pmid= 11925925 |doi= }}

* {{cite journal | author=Brinkmann U |title=Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivo |journal=Novartis Found. Symp. |volume=243 |issue= |pages= 207–10; discussion 210–2, 231–5 |year= 2002 |pmid= 11990778 |doi=10.1002/0470846356.ch15 | series=Novartis Foundation Symposia | isbn=978-0-470-84635-3 }}

* {{cite journal | author=Váradi A, Szakács G, Bakos E, Sarkadi B |title=P glycoprotein and the mechanism of multidrug resistance |journal=Novartis Found. Symp. |volume=243 |issue= |pages= 54–65; discussion 65–8, 180–5 |year= 2002 |pmid= 11990782 |doi=10.1002/0470846356.ch5 | series=Novartis Foundation Symposia | isbn=978-0-470-84635-3 }}

* {{cite journal | author=Hegedus T, Orfi L, Seprodi A, ''et al.'' |title=Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1 |journal=Biochim. Biophys. Acta |volume=1587 |issue= 2–3 |pages= 318–25 |year= 2002 |pmid= 12084474 |doi= }}

* {{cite journal | author=Pallis M, Turzanski J, Higashi Y, Russell N |title=P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype |journal=Leuk. Lymphoma |volume=43 |issue= 6 |pages= 1221–8 |year= 2003 |pmid= 12152989 |doi=10.1080/10428190290026277 }}

* {{cite journal | author=Schaich M, Illmer T |title=Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemia |journal=Leuk. Lymphoma |volume=43 |issue= 7 |pages= 1345–54 |year= 2003 |pmid= 12389613 |doi=10.1080/10428190290033279 }}

* {{cite journal | author=Fromm MF |title=The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans |journal=Adv. Drug Deliv. Rev. |volume=54 |issue= 10 |pages= 1295–310 |year= 2003 |pmid= 12406646 |doi=10.1016/S0169-409X(02)00064-9 }}

* {{cite journal | author=Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Michael M. Gottesman |title=P-glycoprotein: from genomics to mechanism |journal=Oncogene |volume=22 |issue= 47 |pages= 7468–85 |year= 2003 |pmid= 14576852 |doi= 10.1038/sj.onc.1206948 }}

* {{cite journal | author=Jamroziak K, Robak T |title=Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies |journal=Hematology |volume=9 |issue= 2 |pages= 91–105 |year= 2004 |pmid= 15203864 |doi= 10.1080/10245330310001638974 }}

* {{cite journal | author=Ishikawa T, Onishi Y, Hirano H, ''et al.'' |title=Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1) |journal=Biol. Pharm. Bull. |volume=27 |issue= 7 |pages= 939–48 |year= 2005 |pmid= 15256718 |doi=10.1248/bpb.27.939 }}

* {{cite journal | author=Lee W, Lockhart AC, Kim RB, Rothenberg ML |title=Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development |journal=Oncologist |volume=10 |issue= 2 |pages= 104–11 |year= 2005 |pmid= 15709212 |doi= 10.1634/theoncologist.10-2-104 }}

* {{cite journal | author=Gambrelle J, Labialle S, Dayan G, ''et al.'' |title=[Multidrug resistance in uveal melanoma.] |journal=Journal français d'ophtalmologie |volume=28 |issue= 6 |pages= 652–9 |year= 2005 |pmid= 16141933 |doi= }}

* {{cite journal | author=Al-Shawi MK, Omote H |title=The Remarkable Transport Mechanism of P-glycoprotein; a Multidrug Transporter |journal=J. Bioenerg. Biomembr. |volume=37 |issue= 6 |pages= 489–96 |year= 2006 |pmid= 16691488 |doi= 10.1007/s10863-005-9497-5 | pmc=1459968 }}

* {{cite journal | author=Orlowski S, Martin S, Escargueil A |title=P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?) |journal=Cell. Mol. Life Sci. |volume=63 |issue= 9 |pages= 1038–59 |year= 2006 |pmid= 16721513 |doi= 10.1007/s00018-005-5554-9 }}

* {{cite journal | author=Annese V, Valvano MR, Palmieri O, ''et al.'' |title=Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis |journal=World J. Gastroenterol. |volume=12 |issue= 23 |pages= 3636–44 |year= 2006 |pmid= 16773678 |doi= }}

* {{cite journal | author=Sekine I, Minna JD, Nishio K, ''et al.'' |title=A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with lung cancer |journal=Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |volume=1 |issue= 1 |pages= 31–7 |year= 2007 |pmid= 17409824 |doi= }}